These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Transduction with Lentiviral Vectors Altered the Expression Profile of Host MicroRNAs. Huang H; Zhang C; Wang B; Wang F; Pei B; Cheng C; Yang W; Zhao Z J Virol; 2018 Sep; 92(18):. PubMed ID: 29997205 [TBL] [Abstract][Full Text] [Related]
23. Use of DNA microarrays to monitor host response to virus and virus-derived gene therapy vectors. Piersanti S; Martina Y; Cherubini G; Avitabile D; Saggio I Am J Pharmacogenomics; 2004; 4(6):345-56. PubMed ID: 15651896 [TBL] [Abstract][Full Text] [Related]
24. Artificial Virus as Trump-card to Resolve Exigencies in Targeted Gene Delivery. Ajithkumar KC; Pramod K Mini Rev Med Chem; 2018; 18(3):276-286. PubMed ID: 28552048 [TBL] [Abstract][Full Text] [Related]
25. Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systems. Boeckle S; Wagner E AAPS J; 2006; 8(4):E731-42. PubMed ID: 17285739 [TBL] [Abstract][Full Text] [Related]
26. Cancer gene therapy using adeno-associated virus vectors. Park K; Kim WJ; Cho YH; Lee YI; Lee H; Jeong S; Cho ES; Chang SI; Moon SK; Kang BS; Kim YJ; Cho SH Front Biosci; 2008 Jan; 13():2653-9. PubMed ID: 17981740 [TBL] [Abstract][Full Text] [Related]
27. Viral vectors for gene delivery in tissue engineering. Zhang X; Godbey WT Adv Drug Deliv Rev; 2006 Jul; 58(4):515-34. PubMed ID: 16762441 [TBL] [Abstract][Full Text] [Related]
28. Viral and Synthetic RNA Vector Technologies and Applications. Schott JW; Morgan M; Galla M; Schambach A Mol Ther; 2016 Sep; 24(9):1513-27. PubMed ID: 27377044 [TBL] [Abstract][Full Text] [Related]
33. Gene therapy for transplantation with viral vectors--how much of the promise has been realised? Tan PH; Tan PL; George AJ; Chan CL Expert Opin Biol Ther; 2006 Aug; 6(8):759-72. PubMed ID: 16856798 [TBL] [Abstract][Full Text] [Related]
34. Virus-inspired nucleic acid delivery system: Linking virus and viral mimicry. Ni R; Zhou J; Hossain N; Chau Y Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):3-26. PubMed ID: 27473931 [TBL] [Abstract][Full Text] [Related]
35. Viral vectors in cancer immunotherapy: which vector for which strategy? Collins SA; Guinn BA; Harrison PT; Scallan MF; O'Sullivan GC; Tangney M Curr Gene Ther; 2008 Apr; 8(2):66-78. PubMed ID: 18393828 [TBL] [Abstract][Full Text] [Related]
36. Role of viral vectors and virion shells in cellular gene expression. Stilwell JL; Samulski RJ Mol Ther; 2004 Mar; 9(3):337-46. PubMed ID: 15006600 [TBL] [Abstract][Full Text] [Related]
37. No false start for novel pseudotyped vectors. Sanders DA Curr Opin Biotechnol; 2002 Oct; 13(5):437-42. PubMed ID: 12459334 [TBL] [Abstract][Full Text] [Related]
38. Gene therapy with viral vectors. Kootstra NA; Verma IM Annu Rev Pharmacol Toxicol; 2003; 43():413-39. PubMed ID: 12359866 [TBL] [Abstract][Full Text] [Related]
39. Engineering biomaterial systems to enhance viral vector gene delivery. Jang JH; Schaffer DV; Shea LD Mol Ther; 2011 Aug; 19(8):1407-15. PubMed ID: 21629221 [TBL] [Abstract][Full Text] [Related]